Dr. RUMEYSA ATABEY

• 2014Istanbul University Istanbul Faculty of Medicine Medical Oncology
• 2011Istanbul University Istanbul Faculty of Medicine Internal Medicine
• 2006Istanbul University Istanbul Faculty of Medicine

Experience

• 2021Acıbadem Health Group
• 2018 – 2021Istanbul Private Neolife Medical Center
• 2017Isparta Private Meddem Hospital
• 2015 – 2016Bakırköy Dr. Sadi Konuk Training and Research Hospital / Medical Oncology Specialist-Compulsory Service
• 2011Istanbul Kanuni Sultan Süleyman Training and Research Hospital / Internal Medicine Specialist – Compulsory Service

• Lung Cancer Association
• Turkish Medical Oncology Association

• Relationship between interleukin-17A and isolated coronary ectasia. Cytokine.2019 Mar;115:84-88. doi: 10.1016/j.cyto.2018.11.015. Epub 2018 Nov 20. UYGUN T, DEMİR B, TOSUN V, UNGAN I, KURAL A, CIFTCI R, FATULLAYEV F.
• The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer.Mol Biol Rep. 2019 Aug;46(4):4001-4008. doi: 10.1007/s11033-019-04846-z. Epub 2019 May 8. AVSAR M, TAMBAS M, YALNIZ Z, AKDENİZ D, TUNCER SB, KILIC S, SUKRUOGLU ERDOGAN O, CIFTCI R, DAGOGLU N, VATANSEVER S, YAZICI H.
• Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective studyJ Cancer Res Ther. 2018 Sep;14:S774-S778. doi: 10.4103/0973-1482.174544. KOCOGLU H, KARACA M, TURAL D, HOCAOĞLU E, OKUTURLAR Y, FETHULLAHOGLU Z, GUNALDI M, CIFTCI R, TUNA S, YUCIL OK, YUCE OK, OZET G, OZET A, BENEKLİ M
• Serum vascular cell adhesion molecule-1 (VCAM1) level is elevated in colorectal cancer regardless of the tumor stageInternational Journal of Cancer Therapy and Oncology (IJCTO), Doi: 10.14319 CIFTCI RUMEYSA,TAMBAS MAKBULE,KILIÇ LEYLA,TILGEN YASASEVER CEREN,GURDAL NECLA,SERILMEZ MURAT,CELEBI KORAY,PILANCI KEZBAN NUR,DURANYILDIZ HADIYE DERYA
• urrent adjuvant treatment modalities for gastric cancer: From history to the futureWorld Journal of Gastrointestinal Oncology, 8(5), Doi: 10.4251/wjgo.v8.i5. 000. KILIÇ LEYLA,ORDU ÇETIN,YILDIZ IBRAHIM,SEN FATMA,KESKIN SERKAN,FARMER RUMEYSA,PILANCI KEZBAN NUR
• Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancerJournal of Oncological Science, Doi: 10.1016/j.jons.2016.04.003. CIFTCI RUMEYSA,TAS FARUK,BILGIN ELIF,KESKIN SERKAN,YILDIZ IBRAHIM,DURANYILDIZ HADIYE DERYA,SAIP PINAR MUALLA,KARANLIK HASAN,VATANSEVER SEZAI
• Tongue metastasis of melanomaJournal of Cancer Research and Therapeutics, 11(3), 660, Number of Citations: 0, Doi: 10.4103/0973-1482.139526. TAS FARUK,KARABULUT SENEM,YEGEN GÜLÇIN,ÖNDER SEMEN,ÇIFTÇI RUMEYSA
• Renin-angiotensin system blockers may prolong survival of metastatic non-small cell lung cancer patients receivingerlotinibMedicine, 94(22), 887, Number of Citations: 0, Doi: 10.1097/MD.0000000000000887. AYDINER ADNAN,CIFTCI RUMEYSA,SEN FATMA
• Prevalence of Hyponatremia in Oncology Patients and its Relationship with SurvivalTurkish Journal of Clinical Biochemistry, 12(1), 37-43., Doi:none. SEN FATMA,ÇIFTÇI RUMEYSA,ERDEMLI HACI KEMAL,KOCABAS RAMAZAN,KILIÇ LEYLA,YILDIZ IBRAHIM,BOZBEY HAMZA UGUR,ZOBACI ETHEM,ZORLU MUSA
• The Behavior of Turkish Cancer Patients in Fasting During the Holy Month of RamadanJapanese Journal of Clinical Oncology, 44(8), 705-710., Number of Citations: 2, Doi: 10.1093/jjco/hyu070. TAS FARUK,KARABULUT SENEM,CIFTCI RUMEYSA,YILDIZ IBRAHIM,KESKIN SERKAN,KILIÇ LEYLA,DENTAL CLINIC RIAN